Hims & Hers Health Q3 2023 Earnings Report $36.04 -1.00 (-2.69%) As of 09:49 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Earnings HistoryForecast Hims & Hers Health EPS ResultsActual EPS-$0.04Consensus EPS -$0.03Beat/MissMissed by -$0.01One Year Ago EPS-$0.09Hims & Hers Health Revenue ResultsActual Revenue$226.70 millionExpected Revenue$220.08 millionBeat/MissBeat by +$6.62 millionYoY Revenue Growth+56.60%Hims & Hers Health Announcement DetailsQuarterQ3 2023Date11/6/2023TimeAfter Market ClosesConference Call ResourcesConference CallConference Call TranscriptSlide DeckPress ReleaseSEC FilingHIMS Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Slide DeckFull Screen Slide DeckPowered by Remove Ads Hims & Hers Health Earnings HeadlinesHims & Hers Health: Reaching Escape Velocity Goes Unnoticed By The MarketMarch 26 at 9:23 AM | seekingalpha.comWhy Hims & Hers Health Inc (HIMS) Is Surging In 2025?March 26 at 4:22 AM | msn.comElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.March 26, 2025 | InvestorPlace (Ad)Hims & Hers Health, Inc. (NYSE:HIMS) Receives Consensus Rating of "Hold" from BrokeragesMarch 26 at 2:09 AM | americanbankingnews.comThe Case For Hims & Hers: Diversification And Growth Beyond SemaglutideMarch 25 at 7:01 AM | seekingalpha.comHims & Hers Health (HIMS) Shares Spike with Compounded Drug Strategy for GLP-1sMarch 24 at 5:59 PM | markets.businessinsider.comSee More Hims & Hers Health Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Hims & Hers Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hims & Hers Health and other key companies, straight to your email. Email Address About Hims & Hers HealthHims & Hers Health (NYSE:HIMS) operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.View Hims & Hers Health ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of Earnings Upcoming Earnings Bank of New York Mellon (4/11/2025)BlackRock (4/11/2025)JPMorgan Chase & Co. (4/11/2025)Progressive (4/11/2025)Wells Fargo & Company (4/11/2025)Interactive Brokers Group (4/15/2025)Bank of America (4/15/2025)Citigroup (4/15/2025)Johnson & Johnson (4/15/2025)Morgan Stanley (4/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
